Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AL-R Sachet is a nutraceutical combination product developed by Allde Medi Impex, designed to support vascular health and prenatal wellness. The formulation contains L-arginine, a semi-essential amino acid that acts as a precursor to nitric oxide, facilitating vasodilation and improving blood flow. It also includes proanthocyanidins, which are potent antioxidants that protect the endothelium from oxidative stress. The addition of Vitamin B6 (pyridoxine) and folic acid supports the metabolism of homocysteine, elevated levels of which are associated with cardiovascular risk and pregnancy complications. AL-R Sachet is commonly used as a dietary supplement to manage conditions such as pre-eclampsia, intrauterine growth restriction (IUGR), and general endothelial dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AL-R Sachet.